Literature DB >> 9449282

Sequences of homologous beta-lactamases from clinical isolates of Serratia marcescens with different substrate specificities.

N Matsumura1, S Minami, S Mitsuhashi.   

Abstract

Genes for two group 1 beta-lactamases, SRT-1 and SST-1, were sequenced. These beta-lactamases were produced by clinical isolates of Serratia marcescens, isolates GN16694 and GN19450, respectively. The resulting enzymes were 96% identical. SRT-1 hydrolyzed oxyimino cephalosporins, but SST-1 hardly hydrolyzed them. At residue 213 in the third motif, which is conserved among group 1 beta-lactamases, SRT-1 and SST-1 had Lys and Glu, respectively. By site-directed mutagenesis, the substitution of Glu by Lys at residue 213 in SST-1 resulted in an enzyme that hydrolyzed oxyimino cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449282      PMCID: PMC105477     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.

Authors:  K Tsukamoto; R Ohno; T Sawai
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

2.  Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products.

Authors:  M Galleni; F Lindberg; S Normark; S Cole; N Honore; B Joris; J M Frere
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 3.  Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.

Authors:  C C Sanders
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

4.  High-copy-number and low-copy-number plasmid vectors for lacZ alpha-complementation and chloramphenicol- or kanamycin-resistance selection.

Authors:  S Takeshita; M Sato; M Toba; W Masahashi; T Hashimoto-Gotoh
Journal:  Gene       Date:  1987       Impact factor: 3.688

5.  Nucleotide sequence of the Serratia marcescens SR50 chromosomal ampC beta-lactamase gene.

Authors:  K Nomura; T Yoshida
Journal:  FEMS Microbiol Lett       Date:  1990-08       Impact factor: 2.742

6.  Cloning and sequence analysis of blaBIL-1, a plasmid-mediated class C beta-lactamase gene in Escherichia coli BS.

Authors:  A P Fosberry; D J Payne; E J Lawlor; J E Hodgson
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

7.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene.

Authors:  F Lindberg; S Normark
Journal:  Eur J Biochem       Date:  1986-05-02

10.  Role of lysine-67 in the active site of class C beta-lactamase from Citrobacter freundii GN346.

Authors:  K Tsukamoto; K Tachibana; N Yamazaki; Y Ishii; K Ujiie; N Nishida; T Sawai
Journal:  Eur J Biochem       Date:  1990-02-22
View more
  24 in total

1.  Inducible AmpC beta-lactamase of a new member Enterobacteriaceae.

Authors:  Richard Bonnet; Catherine Chanal; Elisabeth Ageron; Danielle Sirot; Christophe De Champs; Patrick Grimont; Jacques Sirot
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 2.  Beta-lactamase nomenclature.

Authors:  George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.

Authors:  Borum Suh; Il Kwon Bae; Juwon Kim; Seok Hoon Jeong; Dongeun Yong; Kyungwon Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

4.  Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.

Authors:  Stathis D Kotsakis; Costas C Papagiannitsis; Eva Tzelepi; Leonidas S Tzouvelekis; Vivi Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

5.  Naturally occurring extended-spectrum cephalosporinases in Escherichia coli.

Authors:  Hedi Mammeri; Laurent Poirel; Nicolas Fortineau; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 6.  Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

Authors:  Krisztina M Papp-Wallace; Andrew R Mack; Magdalena A Taracila; Robert A Bonomo
Journal:  Infect Dis Clin North Am       Date:  2020-09-30       Impact factor: 5.982

7.  Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.

Authors:  A Raimondi; F Sisto; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

8.  Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi.

Authors:  D Nadjar; R Labia; C Cerceau; C Bizet; A Philippon; G Arlet
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.

Authors:  Costas C Papagiannitsis; Leonidas S Tzouvelekis; Eva Tzelepi; Vivi Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.